Feasibility of percutaneous coronary interventions in early postcoronary artery bypass graft occlusion or stenosis

Ameen Abdulmalik1, Abdulrahman Arabi, Abdulwahhab Alroaini

  • 1Department of Cardiology, St. John Hospital & Medical Center, Detroit, Michigan 48236, USA. ameen.abdulmalik@stjohn.org

Insights

Percutaneous coronary intervention (PCI) for early graft occlusion after coronary artery bypass grafting (CABG) is feasible in over half of cases. This approach demonstrated a 14% restenosis rate at one year, with fewer readmissions for ischemia compared to no PCI.

Area of Science:

  • Cardiovascular Medicine
  • Interventional Cardiology
  • Vascular Surgery

Background:

  • Coronary artery bypass grafting (CABG) patients often have complex anatomy unsuitable for percutaneous coronary intervention (PCI).
  • These patients face increased risk of early graft occlusion, with limited data on PCI feasibility for this complication.

Purpose of the Study:

  • To evaluate the feasibility and outcomes of PCI in treating early graft occlusion following CABG.
  • To compare PCI outcomes with non-PCI management in this high-risk patient group.

Main Methods:

  • Retrospective chart review of 46 patients with recurrent ischemia within three months post-CABG.
  • Analysis included graft occlusion/stenosis, PCI success rates, and one-year follow-up for ischemia readmission and restenosis.

Main Results:

  • Of 156 grafts, 63 were occluded/stenosed; 27 (43%) were not amenable to PCI.
  • Successful PCI was performed on 34 grafts (54%) in 23 patients, with no deaths.
  • At one year, 14% of PCI-treated vessels restenosed; 6 of 23 patients were readmitted with ischemia.
  • In the no-PCI group, 11 of 23 patients were readmitted with ischemia, including one death.

Conclusions:

  • PCI is a safe and feasible option for treating early post-CABG graft occlusion in selected patients.
  • PCI success rates were comparable for native vessels and occluded grafts.
  • The one-year target vessel restenosis rate after successful PCI was 14%, with favorable clinical outcomes compared to non-PCI management.
Abstract

Related Concept Videos

Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
Peripheral Artery Disease III: Interprofessional Care01:27

Peripheral Artery Disease III: Interprofessional Care

Peripheral Artery Disease (PAD) is characterized by narrowed arteries that diminish blood flow to the extremities. Effective management of PAD requires an interprofessional approach involving various healthcare professionals. The critical aspects of interprofessional care for PAD patients focus on risk factor modification, drug therapy, exercise therapy, nutrition therapy, critical limb ischemia care, and interventional radiology and surgical procedures.The primary treatment goal for PAD...
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...